Clincosm LogoSign in Get a demo

parkinson disease

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in Worldwide (Placebo, PF-06649751 low dose (1 mg QD), PF-06649751 middle dose 1 (3 mg QD))

Terminated
Has Results
  • Parkinson Disease
  • Placebo
  • +4 more
  • Phoenix, Arizona
  • +56 more
Oct 28, 2020

Parkinson Disease Trial in Worldwide (Placebo, PF-06649751)

Terminated
Has Results
  • Parkinson Disease
  • Phoenix, Arizona
  • +36 more
Oct 28, 2020

Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules

Completed
Has Results
  • Parkinson Disease
  • Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
  • +2 more
  • Birmingham, Alabama
  • +23 more
Jul 21, 2020

Parkinson Disease Trial in Worldwide (DaTscan)

Unknown status
  • Parkinson Disease
  • Birmingham, Alabama
  • +33 more
Jul 15, 2020

Parkinson Disease Trial in United States (Personal KinetiGraph™ (PKG™))

Active, not recruiting
  • Parkinson Disease
  • Personal KinetiGraph™ (PKG™)
  • Sacramento, California
  • +11 more
Mar 3, 2020

Parkinson Disease Trial in Canada, United States (Isradipine, Placebo (for Isradipine))

Completed
Has Results
  • Parkinson Disease
  • Birmingham, Alabama
  • +53 more
Jan 7, 2020

Excessive Sleepiness, Parkinson Disease Trial in United States (JZP-110, Placebo)

Completed
Has Results
  • Excessive Sleepiness
  • Parkinson Disease
  • Los Angeles, California
  • +24 more
Jan 3, 2020

Parkinson Disease Trial in Worldwide (ropinirole/L-dopa, /L-dopa)

Completed
Has Results
  • Parkinson Disease
  • Fountain Valley, California
  • +51 more
Jun 18, 2018

Parkinson Disease Trial in Worldwide (ropinirole monotherapy, monotherapy)

Completed
Has Results
  • Parkinson Disease
  • ropinirole monotherapy
  • placebo monotherapy
  • Fountain Valley, California
  • +33 more
Jun 18, 2018

Parkinson Disease Trial in Worldwide (Ropinirole)

Completed
  • Parkinson Disease
  • Birmingham, Alabama
  • +75 more
Mar 21, 2017

Parkinson Disease, Parkinson's Disease Trial in Worldwide (Ropinirole XL (formerly CR))

Completed
Has Results
  • Parkinson Disease
  • Parkinson's Disease
  • Ropinirole XL (formerly CR)
  • Birmingham, Alabama
  • +74 more
Mar 21, 2017

Parkinson's Disease, Parkinson Disease, Dyskinesias Trial in United States (ropinirole controlled-release (REQUIP CR) for RLS)

Completed
  • Parkinson's Disease
  • +2 more
  • ropinirole controlled-release (REQUIP CR) for RLS
  • Anniston, Alabama
  • +69 more
Jan 16, 2017

Parkinson Disease Trial in Germany, Spain, United States (Spheramine (BAY86-5280), Placebo)

Terminated
  • Parkinson Disease
  • Spheramine (BAY86-5280)
  • Placebo
  • Birmingham, Alabama
  • +14 more
Sep 23, 2015

Parkinson Disease Trial in Worldwide (pramipexole)

Completed
Has Results
  • Parkinson Disease
  • Brimingham, Alabama
  • +98 more
May 7, 2014

Parkinson Disease Trial in United States (Mirapex, Requip)

Completed
Has Results
  • Parkinson Disease
  • Birmingham, Alabama
  • +20 more
Feb 17, 2014

Parkinson Disease Trial in Canada, United States (NS 2330)

Completed
  • Parkinson Disease
  • NS 2330
  • Peoria, Arizona
  • +54 more
Oct 28, 2013

Parkinson Disease Trial in United States (Ropinirole XL (formerly CR))

Completed
Has Results
  • Parkinson Disease
  • Ropinirole XL (formerly CR)
  • Scottsdale, Arizona
  • +9 more
May 2, 2013

Parkinson Disease Trial in Canada, United States (Isradipine CR 5mg, Isradipine CR 10mg, Isradipine CR 20mg)

Completed
Has Results
  • Parkinson Disease
  • Isradipine CR 5mg
  • +3 more
  • Sunnyvale, California
  • +19 more
Apr 16, 2013

Parkinson Disease Trial in Canada, United States (Coenzyme Q10 with vitamin E, with vitamin E)

Terminated
Has Results
  • Parkinson Disease
  • Coenzyme Q10 with vitamin E
  • placebo with vitamin E
  • Birmingham, Alabama
  • +67 more
Dec 24, 2012

Parkinson Disease Trial in Canada, Puerto Rico, United States (CEP-1347 10mg, CEP1347 25mg, CEP-1347 50mg)

Terminated
  • Parkinson Disease
  • CEP-1347 10mg
  • +3 more
  • Phoenix, Arizona
  • +65 more
May 8, 2012

Parkinson's Research: The Organized Genetics Initiative

Completed
  • Parkinson Disease
    • Phoenix, Arizona
    • +57 more
    Feb 15, 2011

    PRECEPT Study Cohort

    Unknown status
    • Parkinson Disease
      • Phoenix, Arizona
      • +54 more
      Mar 26, 2008

      Parkinson Disease Trial in Worldwide (sumanirole)

      Terminated
      • Parkinson Disease
      • Birmingham, Alabama
      • +109 more
      Jan 17, 2007

      Parkinson Disease Trial in Worldwide (sumanirole, ropinirole)

      Completed
      • Parkinson Disease
      • Hot Springs, Arkansas
      • +101 more
      Jun 6, 2006

      Parkinson Disease Trial in Worldwide (sumanirole)

      Completed
      • Parkinson Disease
      • Birmingham, Alabama
      • +134 more
      Jun 6, 2006